Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson's disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER.

LeWitt PA, Boroojerdi B, Surmann E, Poewe W; SP716 Study Group; SP715 Study Group.

J Neural Transm (Vienna). 2013 Jul;120(7):1069-81. doi: 10.1007/s00702-012-0925-5. Epub 2012 Dec 4.

2.

Acute hospitalisation needs of adults admitted to public facilities in the Cape Town Metro district.

de Vries E, Raubenheimer P, Kies B, Burch VC.

S Afr Med J. 2011 Sep 27;101(10):760-4.

PMID:
22272858
3.

Irbesartan in patients with atrial fibrillation.

ACTIVE I Investigators, Yusuf S, Healey JS, Pogue J, Chrolavicius S, Flather M, Hart RG, Hohnloser SH, Joyner CD, Pfeffer MA, Connolly SJ.

N Engl J Med. 2011 Mar 10;364(10):928-38. doi: 10.1056/NEJMoa1008816.

4.

Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER).

Trenkwalder C, Kies B, Rudzinska M, Fine J, Nikl J, Honczarenko K, Dioszeghy P, Hill D, Anderson T, Myllyla V, Kassubek J, Steiger M, Zucconi M, Tolosa E, Poewe W, Surmann E, Whitesides J, Boroojerdi B, Chaudhuri KR; Recover Study Group.

Mov Disord. 2011 Jan;26(1):90-9. doi: 10.1002/mds.23441. Epub 2010 Nov 18.

5.

Cavernous sinus syndrome, an atypical presentation of tertiary syphilis: case report and review of the literature.

Noel CB, Moeketsi K, Kies B.

Clin Neurol Neurosurg. 2011 Jan;113(1):65-7. doi: 10.1016/j.clineuro.2010.08.007. Epub 2010 Sep 29.

PMID:
20884116
6.

Dose comparisons of clopidogrel and aspirin in acute coronary syndromes.

CURRENT-OASIS 7 Investigators, Mehta SR, Bassand JP, Chrolavicius S, Diaz R, Eikelboom JW, Fox KA, Granger CB, Jolly S, Joyner CD, Rupprecht HJ, Widimsky P, Afzal R, Pogue J, Yusuf S.

N Engl J Med. 2010 Sep 2;363(10):930-42. doi: 10.1056/NEJMoa0909475. Erratum in: N Engl J Med. 2010 Oct 14;363(16):1585.

7.

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial.

Mehta SR, Tanguay JF, Eikelboom JW, Jolly SS, Joyner CD, Granger CB, Faxon DP, Rupprecht HJ, Budaj A, Avezum A, Widimsky P, Steg PG, Bassand JP, Montalescot G, Macaya C, Di Pasquale G, Niemela K, Ajani AE, White HD, Chrolavicius S, Gao P, Fox KA, Yusuf S; CURRENT-OASIS 7 trial investigators.

Lancet. 2010 Oct 9;376(9748):1233-43. doi: 10.1016/S0140-6736(10)61088-4.

PMID:
20817281
8.

Guideline for the treatment of Parkinson's disease.

Carr J, Kies B, Fine J; Movement Disorders Group of South Africa.

S Afr Med J. 2009 Oct;99(10):755-6, 758. No abstract available.

PMID:
20128276
9.

Dabigatran versus warfarin in patients with atrial fibrillation.

Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L; RE-LY Steering Committee and Investigators.

N Engl J Med. 2009 Sep 17;361(12):1139-51. doi: 10.1056/NEJMoa0905561. Epub 2009 Aug 30. Erratum in: N Engl J Med. 2010 Nov 4;363(19):1877.

10.

Effect of clopidogrel added to aspirin in patients with atrial fibrillation.

ACTIVE Investigators, Connolly SJ, Pogue J, Hart RG, Hohnloser SH, Pfeffer M, Chrolavicius S, Yusuf S.

N Engl J Med. 2009 May 14;360(20):2066-78. doi: 10.1056/NEJMoa0901301. Epub 2009 Mar 31.

12.

IV amantadine improves chorea in Huntington's disease: an acute randomized, controlled study.

Heckmann JM, Legg P, Sklar D, Fine J, Bryer A, Kies B.

Neurology. 2004 Aug 10;63(3):597-8; author reply 597-8. No abstract available.

PMID:
15304616
13.

Zolmitriptan versus sumatriptan for the acute oral treatment of migraine: a randomized, double-blind, international study.

Gruffyd-Jones K, Kies B, Middleton A, Mulder LJ, Røsjø Ø, Millson DS.

Eur J Neurol. 2001 May;8(3):237-45.

PMID:
11328332
14.

Optimization of phenytoin therapy in adults with epilepsy in the Western Cape, South Africa.

Valodia PN, Seymour MA, Kies BM, Folb PI.

J Clin Pharm Ther. 1999 Oct;24(5):381-5.

PMID:
10583702
15.

Benefits of a clinical pharmacokinetic service in optimising phenytoin use in the western Cape.

Valodia P, Seymour MA, Kies BM, Folb PI.

S Afr Med J. 1998 Jul;88(7):873-5.

PMID:
9698715
16.

Benign hereditary cerebellar ataxia with extensive thermoanalgesia.

Pollock M, Kies B.

Brain. 1990 Aug;113 ( Pt 4):857-65.

PMID:
2168779
17.

'Bombing' the patient with epilepsy.

Silber MH, Philcox DV, Eastman R, Kies B.

S Afr Med J. 1988 Aug 6;74(3):138. No abstract available.

PMID:
3399994
18.

Autopsy-confirmed multiple sclerosis in a white South African. A case report.

Kies BM, Rutherfoord GS.

S Afr Med J. 1985 Sep 28;68(7):485-8.

PMID:
4049163
19.

HLA antigens in multiple sclerosis in coloured South Africans.

Fewster ME, Kies B.

J Neurol Sci. 1984 Nov-Dec;66(2-3):175-81.

PMID:
6597862
20.

Choline in hereditary ataxia.

Philcox DV, Kies B.

Br Med J. 1979 Sep 8;2(6190):613. No abstract available.

Supplemental Content

Loading ...
Support Center